Dongkook Pharmaceutical, Stock Price +0.52% at This Time... Institutional Investors Net Buy 153,593 Shares in the Last 5 Days

As of 2:30 PM on the 28th, Dongkook Pharmaceutical is trading at 29,100 KRW, up 0.52% from the previous day. The trading volume is 319,581 shares, which is 90.24% of the previous day's volume. Dongkook Pharmaceutical is known as a prescription drug company.

On December 23, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "Sales growth in the export sector and the penetration effect in the domestic online cosmetics market are expected to accelerate in 2021. Dongkook Pharmaceutical’s OTC division, which has built high brand awareness rather than focusing on generics, shows remarkable sales growth. Synergy with the healthcare division using well-known OTC brands such as ‘Madeca Cream’ is also possible. Given the increasing interest in mid-sized pharmaceutical companies, it is reasonable to apply a premium to Dongkook Pharmaceutical compared to its peers, as it possesses distinctive differentiating points." He set the target price for Dongkook Pharmaceutical at 41,000 KRW.

Over the past five days, individual investors have net sold 139,989 shares of Dongkook Pharmaceutical, while foreigners and institutions have net bought 8,640 shares and 153,593 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.